SATB1 vital for maintenance of hematopoietic stem cells

July 04, 2018

Blood plays the important role of transporting oxygen and hormones necessary for the human body. Blood contains blood cells, such as erythrocytes, neutrophils, and lymphocytes, which are generated from hematopoietic stem cells, or hematopoietic stem cells (HSCs).

HSCs possess the abilities of multipotency (the ability to differentiate into all functional blood cells) and self-renewal (the ability to give rise to HSCs without differentiation). A group of researchers led by Takafumi Yokota at Osaka University clarified that the Special AT-rich Sequence Binding Protein 1 (SATB1), a nuclear global chromatin organizer that regulates chromatin structure, played an important role in differentiation of HSCs into lymphocytic lineages. (Satoh et al., Immunity, 2013) However, they obtained these findings from experiments using genetically engineered cells and mouse fetuses, so the biological processes occurring in adults were not fully understood. In addition, it remained unclear how differentiation of lymphoid-lineage cells began.

This group revealed that expression of SATB1 was involved in both differences in HSC self-renewal ability and differences in the ability of HSCs to differentiate into lymphocytic lineages. Their research results were published in Cell Reports.

The researchers generated genetically modified mice in which SATB1 was deficient only in hematopoietic cells and reporter mice in which a red fluorescent protein was expressed under control of the endogenous SATB1 promoter. They examined them to confirm that SATB1 was essential for maintaining function of adult HSCs.

In addition, they revealed that (1) both high SATB1 expression and low SATB1 expression were present in HSCs, (2) the volume of SATB1 expression changed during HSC self-renewal, and (3) higher SATB1 expression had greater lymphoid differentiation ability.

Lead author Yukiko Doi says, "We generated genetically engineered mice to observe a phenomenon in the initial stage of differentiation of HSCs into lymphocytic lineages in adult mice."

This group's achievements will deepen an understanding of the mechanism behind differentiation of HSCs into lymphocytic lineages. They will become a research base for treatment of diseases caused by immune disorders, such as infectious diseases and disorders of the hematopoietic system, through application to regenerative medicine and gene therapy.
-end-
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: http://resou.osaka-u.ac.jp/en/top

Osaka University

Related Blood Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

Method to derive blood vessel cells from skin cells suggests ways to slow aging
Salk scientists have used skin cells called fibroblasts from young and old patients to successfully create blood vessels cells that retain their molecular markers of age.

Cancer cells take over blood vessels to spread
In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

COVID-19 causes 'hyperactivity' in blood-clotting cells
Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Blood transfusions: Fresh red blood cells no better than older ones
Findings from the ABC-PICU study on critically ill children may alter policies at hospitals where fresh red cells are preferentially used.

Changes in blood flow tell heart cells to regenerate
Altered blood flow resulting from heart injury switches on a communication cascade that reprograms heart cells and leads to heart regeneration in zebrafish.

Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.

Study gives new perspective on production of blood cells and immune cells
A new study provides a thorough accounting of blood cell production from hematopoietic stem cells.

White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.

Read More: Blood Cells News and Blood Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.